CVS
50
2
DHR
38
3
CAT
62
7
BSX
70
2
AMAT
42
6
VNO
50
-9
OI
42
5
AXP
69
3
PVH
57
5
BXP
52
2
ALL
51
8
KR
38
4
BBY
36
-4
DOV
68
7
BRK.B
42
2
PEG
67
5
APH
67
3
C
60
2
NSC
57
7
SIG
49
6
CVS
50
2
DHR
38
3
CAT
62
7
BSX
70
2
AMAT
42
6
VNO
50
-9
OI
42
5
AXP
69
3
PVH
57
5
BXP
52
2
ALL
51
8
KR
38
4
BBY
36
-4
DOV
68
7
BRK.B
42
2
PEG
67
5
APH
67
3
C
60
2
NSC
57
7
SIG
49
6
Financhill
Back

Regeneron Pharmaceuticals Vs. AbbVie Industry Stock Comparison

Sell
39

REGN
Regeneron Pharmaceuticals

Last Price:
744.42
Seasonality Move:
14.6%
Sell
39

ABBV
AbbVie

Last Price:
171.70
Seasonality Move:
6.01%
Sell
39
Regeneron Pharmaceuticals (REGN) is a Sell

Is Regeneron Pharmaceuticals a Buy, Sell or Hold?

  • The current Regeneron Pharmaceuticals [REGN] share price is $744.50. The Score for REGN is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • REGN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
AbbVie (ABBV) is a Sell

Is AbbVie a Buy, Sell or Hold?

  • The current AbbVie [ABBV] share price is $171.73. The Score for ABBV is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • ABBV is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

REGN Stock Price Chart

What is Regeneron Pharmaceuticals's stock price today?

  • The Regeneron Pharmaceuticals share price today is $744.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and REGN is experiencing slight selling pressure.

ABBV Stock Price Chart

What is AbbVie's stock price today?

  • The AbbVie share price today is $171.73
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ABBV is experiencing buying pressure, which is a positive indicator for future bullish movement.

REGN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -61.44 Sell
Relative Strength Index (14 RSI): 13.71 Sell
Chaikin Money Flow: -202813 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (775.32 - 928.52) Sell
Bollinger Bands (100): (911.38 - 1161.56) Sell

ABBV Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -7.13 Sell
Relative Strength Index (14 RSI): 34.98 Sell
Chaikin Money Flow: 4932185 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (172.16 - 199.34) Sell
Bollinger Bands (100): (176.3 - 198.68) Sell

REGN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 769.89 Sell
20-day SMA: 825.31 Sell
50-day SMA: 956.7 Sell
200-day SMA: 1002.38 Sell
8-day EMA: 768.55 Sell
20-day EMA: 823.78 Sell
50-day EMA: 920.48 Sell
200-day EMA: 975.85 Sell

ABBV Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 168.55 Buy
20-day SMA: 185.1 Sell
50-day SMA: 189.91 Sell
200-day SMA: 178.79 Sell
8-day EMA: 171.97 Sell
20-day EMA: 180.2 Sell
50-day EMA: 186.23 Sell
200-day EMA: 178.59 Sell

Regeneron Pharmaceuticals Earnings Growth & REGN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.25 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.42 per share, and an increase next year of $0.41 per share.

AbbVie Earnings Growth & ABBV Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.28 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.19 per share, and an increase next year of $1.21 per share.

Regeneron Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

AbbVie Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):